Biomarkers in Cardiovascular Disease

Get a quick, expert overview of the ways in which biomarkers can be used to assess and guide the management of cardiovascular disease in the clinical setting. This concise, clinically-focused resource by Dr. Vijay Nambi consolidates today’s available information on this rapidly changing topic into one convenient resource, making it an ideal, easy-to-digest reference for cardiology practitioners, fellows, and residents. Covers lab standards and statistical interpretation of biomarkers with a clinical focus. Discusses relevant conditions such as hypertension and diabetes as key markers of injury and prognosis. Includes current information on biomarkers to assess and guide the management of heart failure, acute coronary syndrome, chest pain, shortness of breath, and more. Concludes the book with a timely chapter on how biomarkers may guide cardiologists in the future.

Produk Detail:

  • Author : Vijay Nambi
  • Publisher : Elsevier Health Sciences
  • Pages : 400 pages
  • ISBN : 0323548369
  • Rating : 4/5 from 21 reviews
CLICK HERE TO GET THIS BOOKBiomarkers in Cardiovascular Disease

Biomarkers in Cardiovascular Disease

Biomarkers in Cardiovascular Disease
  • Author : Vijay Nambi
  • Publisher : Elsevier Health Sciences
  • Release : 27 November 2018
GET THIS BOOKBiomarkers in Cardiovascular Disease

Get a quick, expert overview of the ways in which biomarkers can be used to assess and guide the management of cardiovascular disease in the clinical setting. This concise, clinically-focused resource by Dr. Vijay Nambi consolidates today’s available information on this rapidly changing topic into one convenient resource, making it an ideal, easy-to-digest reference for cardiology practitioners, fellows, and residents. Covers lab standards and statistical interpretation of biomarkers with a clinical focus. Discusses relevant conditions such as hypertension and

Biomarkers in Cardiovascular Disease

Biomarkers in Cardiovascular Disease
  • Author : Victor R. Preedy,Vinood B. Patel
  • Publisher : Springer
  • Release : 11 March 2016
GET THIS BOOKBiomarkers in Cardiovascular Disease

In the past decade there has been a major sea change in the way disease is diagnosed and investigated due to the advent of high throughput technologies, such as microarrays, lab on a chip, proteomics, genomics, lipomics, metabolomics etc. These advances have enabled the discovery of new and novel markers of disease relating to autoimmune disorders, cancers, endocrine diseases, genetic disorders, sensory damage, intestinal diseases etc. In many instances these developments have gone hand in hand with the discovery of

Cardiovascular Biomarkers

Cardiovascular Biomarkers
  • Author : David A. Morrow
  • Publisher : Springer Science & Business Media
  • Release : 28 April 2010
GET THIS BOOKCardiovascular Biomarkers

In the four pages committed to a discussion of myocardial infarction in the first edition of Harrison’s Principles of Internal Medicine, published in 1950, there was no mention of use of the laboratory for management of patients. Thirty years later, when the first edition of Braunwald’s Heart Disease, A Textbook of Cardiovascular Medicine was published, 2 out of the 1943 pages in the text contained a discussion of the laboratory examinations in acute myocardial infarction. Our knowledge base of the multitude

Biomarker

Biomarker
  • Author : Ghousia Begum
  • Publisher : BoD – Books on Demand
  • Release : 05 September 2018
GET THIS BOOKBiomarker

This book investigates the emerging use of biomarkers as a diagnostic tool for the identification of patients with an abnormal condition or as a tool for staging the extent of disease, as an indicator of disease prognosis. Chapters in Part I focus on biomarkers for cancer, including breast cancer and pancreatic cancer, as well as circulating microRNA profiling in cancer biomarker discovery. Chapters in Part II focus on biomarkers of other diagnoses/diseases, including sepsis, childhood renal diseases, pulmonary diseases,

Cardiac Biomarkers

Cardiac Biomarkers
  • Author : Alan S. Maisel,Allan S. Jaffe
  • Publisher : Springer
  • Release : 24 October 2016
GET THIS BOOKCardiac Biomarkers

This book covers ACS and Heart Failure, the chapters represent the most current, up to date and knowledgeable content on the topic available. It is written by the worlds most respected leaders in biomarkers, with a majority emphasis on what clinicians need to know. The Editors and their contributors have provided algorithms, annotated case discussions and caveats. They cover biomarkers to predict risk of heart disease, biomarkers of cardiorenal disease , and conclude with a section on new and emerging biomarkers.

Cardiac Biomarkers in Clinical Practice

Cardiac Biomarkers in Clinical Practice
  • Author : James L. Januzzi
  • Publisher : Jones & Bartlett Learning
  • Release : 24 July 2021
GET THIS BOOKCardiac Biomarkers in Clinical Practice

Cardiac Biomarkers in Clinical Practice was just honored with 4 Stars from Doody's Book Review! Cardiac Biomarkers in Clinical Practice presents a case based approach to biomarkers in heart diseases including heart failure, ischemic heart disease, and outpatient. Divided into six sections, this book provides physicians and other health care providers with a clear understanding of the role of biomarkers in clinical cardiovascular medicine.

Biomarkers in Cardiovascular Diseases

Biomarkers in Cardiovascular Diseases
  • Author : Dimitris Tousoulis,Christodoulos Stefanadis
  • Publisher : CRC Press
  • Release : 29 July 2013
GET THIS BOOKBiomarkers in Cardiovascular Diseases

The establishment of precise and reliable biomarker tests for the early stages of cardiovascular disease is of great importance and can be the cornerstone in the prevention of future cardiovascular disease (CVD). Furthermore, some biomarkers may provide important information concerning the pathogenesis of CVD or appear to be useful in risk stratification, in CVD diagnosis, or in monitoring therapy; many others may be risk factors themselves, representing therefore potential targets of therapy. The ideal biomarker should have the following characteristics:

Cardiac Biomarkers

Cardiac Biomarkers
  • Author : Alan S Maisel
  • Publisher : JP Medical Ltd
  • Release : 01 January 2012
GET THIS BOOKCardiac Biomarkers

Cardiac Biomarkers describes the most recent developments in the field of biomarkers, providing best practice and current guidelines. It also discusses how these guidelines may alter in the future. With contributions from internationally-based clinicians and scientists, this book includes almost 100 detailed images and illustrations. Topics covered include: Markers of Cardiac Arrest, Markers of Cardiac Ischemia, Natriuretic Peptides for Heart Failure, Biomarkers in Cardio Renal Disease and Future Developments.

Biomarkers of Kidney Disease

Biomarkers of Kidney Disease
  • Author : Charles L. Edelstein
  • Publisher : Academic Press
  • Release : 08 November 2016
GET THIS BOOKBiomarkers of Kidney Disease

Biomarkers of Kidney Disease, Second Edition, focuses on the basic and clinical research of biomarkers in common kidney diseases, detailing the characteristics of an ideal biomarker. The latest techniques for biomarker detection, including metabolomics and proteomics are covered in the book. This comprehensive book details the latest advances made in the field of biomarker research and development in kidney diseases. The book is an ideal companion for those interested in biomarker research and development, proteomics and metabolomics, kidney diseases, statistical

Role of Biomarkers in Medicine

Role of Biomarkers in Medicine
  • Author : Mu Wang,Frank Witzmann
  • Publisher : BoD – Books on Demand
  • Release : 17 August 2016
GET THIS BOOKRole of Biomarkers in Medicine

The use of biomarkers in basic and clinical research has become routine in many areas of medicine. They are accepted as molecular signatures that have been well characterized and repeatedly shown to be capable of predicting relevant disease states or clinical outcomes. In Role of Biomarkers in Medicine, expert researchers in their individual field have reviewed many biomarkers or potential biomarkers in various types of diseases. The topics address numerous aspects of medicine, demonstrating the current conceptual status of biomarkers

Proof and Concepts in Rapid Diagnostic Tests and Technologies

Proof and Concepts in Rapid Diagnostic Tests and Technologies
  • Author : Shailendra K. Saxena
  • Publisher : BoD – Books on Demand
  • Release : 07 September 2016
GET THIS BOOKProof and Concepts in Rapid Diagnostic Tests and Technologies

This book gives a comprehensive overview of the recent advancements and developments of rapid diagnostic tests (RDTs) and technologies, which are quite novel approaches and might be used as laboratory bench manual for the rapid diagnosis of the various disease conditions. The book focuses on various aspects and properties of RDTs, point-of-care tests (POCTs), quality control, assurance, calibration, safety, nano-/microfluidic technologies, and fusion with DNA technologies. I hope that this work might increase the interest in this field of

Cardiac Markers

Cardiac Markers
  • Author : Alan H. B. Wu
  • Publisher : Springer Science & Business Media
  • Release : 12 June 2003
GET THIS BOOKCardiac Markers

In this greatly enlarged and thoroughly updated edition of his much praised Cardiac Markers, Alan Wu and his contributors focus on the use of markers in the practice of cardiology and-for the first time-on the use of natriuretic peptides for congestive heart failure. Here, leading international authorities in clinical chemistry and laboratory medicine, cardiology, emergency medicine, and the in vitro diagnostics industry describe the state-of-the-art uses of cardiac markers when treating coronary artery disease, and discuss in detail how they

Circulating Biomarkers in Cardiovascular Disease - Book Edition of Disease Markers

Circulating Biomarkers in Cardiovascular Disease - Book Edition of Disease Markers
  • Author : E. Ingelsson
  • Publisher : Ios PressInc
  • Release : 15 November 2009
GET THIS BOOKCirculating Biomarkers in Cardiovascular Disease - Book Edition of Disease Markers

This publication gives a comprehensive overview of the current state of knowledge regarding circulating biomarkers in cardiovascular disease (CVD), a field which has a long history of using biomarkers for risk stratification. The blood lipid profile, including cholesterol fractions, was one of the first biomarkers to be established as a risk factor for CVD. The main focus of this work is the use of biomarkers in the risk stratification of healthy individuals and the early detection of subclinical disease.

Biomarkers in Drug Development

Biomarkers in Drug Development
  • Author : Michael R. Bleavins,Claudio Carini,Mallé Jurima-Romet,Ramin Rahbari
  • Publisher : John Wiley & Sons
  • Release : 20 September 2011
GET THIS BOOKBiomarkers in Drug Development

Discover how biomarkers can boost the success rate of drugdevelopment efforts As pharmaceutical companies struggle to improve the success rateand cost-effectiveness of the drug development process, biomarkershave emerged as a valuable tool. This book synthesizes and reviewsthe latest efforts to identify, develop, and integrate biomarkersas a key strategy in translational medicine and the drugdevelopment process. Filled with case studies, the bookdemonstrates how biomarkers can improve drug development timelines,lower costs, facilitate better compound selection, reducelate-stage attrition, and open the door

Biomarkers in Heart Disease

Biomarkers in Heart Disease
  • Author : James de Lemos
  • Publisher : John Wiley & Sons
  • Release : 26 January 2009
GET THIS BOOKBiomarkers in Heart Disease

Biomarkers in Heart Disease is the first title in the AHAClinical Series and is aimed at meeting the needs of clinicians,providing cardiologists, internists, emergency physicians,laboratorians, and other healthcare providers with a clearunderstanding of the role of biomarkers in contemporarycardiovascular medicine. The book covers both the strengths and pitfalls of currentlyavailable markers, and provides information on the most promisingbiomarkers that are likely to impact practice in the next fewyears. It is divided into four parts, organized around clinicalscenarios rather